Hansoh: Merck Joins Obesity Pill Race With $2B Hansoh Deal
The Hansoh deal will let Merck compete in the crowded oral GLP-1 space alongside fellow pharma giants Eli Lilly, Novo Nordisk and Roche.
Read full article »
President
Lyu Aifeng
Hansoh is a China-based pharmaceutical company that develops and commercializes drugs that cure diseases such as schizophrenia, lung cancer and diabetes for patients.
Read more